Anhui Huaheng Biotechnology Hits Day High with 5.95% Surge

Anhui Huaheng Biotechnology Co., Ltd. has experienced a notable increase of 5.95% on March 11, 2026, reaching an intraday high of CNY 34.46. This performance stands out against the backdrop of the China Shanghai Composite, which only saw a modest gain of 0.25% on the same day. In terms of recent performance, Anhui Huaheng has shown a weekly increase of 8.71%, significantly outperforming the broader market index, which rose by 1.25%. However, the stock's one-month performance reflects a decline of 2.75%, contrasting with the Shanghai Composite's slight gain of 0.04%. Over the past year, Anhui Huaheng's stock has generated a return of 12.48%, although this is below the Shanghai Composite's impressive 22.3% return. Despite the recent uptick, the company has faced challenges, including a decline in profits by 63.9% over the past year and negative results for five consecutive quarters. With a market capitalization of CNY 7,832 million, Anhui Huaheng operates within the pharmaceuticals and biotechnology sector, characterized by a P/E ratio of 59.00 and a dividend yield of 0.50%.